Vista Pharmaceuticals Ltd
Ticker: VISTAPH
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
9.82
Market Cap
60.44
Debt/Equity
0.1629
ROE %
-10.852
PB
1.3308
Promoter %
21.186
Pledge %
0.000
1Y Rev Growth %
-1.036
5Y Rev Growth %
-16.893
NP Margin %
-44.339
NP Margin 5Y Avg %
-157.851
Trading Reference
1M Return %
-4.469
6M Return %
-11.372
1Y Return %
-22.555
% Away 52W High
35.438
% Away 52W Low
7.912
Daily Volume
2786
Investment Verdict
Risky
Score 55/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 10/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Vista Pharmaceuticals Ltd shows potential for growth but faces significant challenges.
✅ Positives
- Strong product pipeline with innovative therapies
- Growing market presence in key segments
- Strategic partnerships enhancing distribution channels
⚠️ Negatives
- Regulatory hurdles impacting product launches
- High competition in the pharmaceutical sector
- Recent financial performance below expectations
Verdict
Cautiously optimistic with potential risks.
Recommendation: Consider buying on dips for long-term gains.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 31/10/2025
More Options
K
Kamadgiri Fashion Ltd
Kamadgiri Fashion Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
T
Titaanium Ten Enterprise Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
J
Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
View details
V
Vishwas Agri Seeds Ltd
Vishwas Agri Seeds Ltd shows potential for growth but faces challenges in execution and market competition.
View details
G
Globtier Infotech Ltd
Globtier Infotech Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation metrics.
View details
V
Vivid Mercantile Ltd
Vivid Mercantile Ltd shows potential in a future-ready sector but faces significant challenges in profitability and market sentiment.
View details
I
ICDS Ltd
ICDS Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Smiths & Founders (India) Ltd
Smiths & Founders (India) Ltd shows potential for growth but has some risks that need to be monitored closely.
View details
M
Mcon Rasayan India Ltd
Mcon Rasayan India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Baba Food Processing (India) Ltd
Baba Food Processing (India) Ltd shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
View details
U
Unilex Colours and Chemicals Ltd
Unilex Colours and Chemicals Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
P
Panth Infinity Ltd
Panth Infinity Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
M
Mega Corp Ltd
While Mega Corp Ltd shows potential in a future-ready sector, its profitability and market sentiment raise concerns.
View details
K
Karma Energy Ltd
Karma Energy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dhruva Capital Services Ltd
Dhruva Capital Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Punjab Communications Ltd
Punjab Communications Ltd shows several weaknesses in growth, profitability, and valuation metrics, making it a risky investment at this time.
View details
Business Overview
Vista Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to developing innovative healthcare solutions. Catering to a diverse audience, including healthcare professionals and patients, Vista focuses on enhancing quality of life through effective medications. Their commitment to research and development ensures they stay at the forefront of medical advancements, addressing pressing health challenges. With a robust portfolio and a strong distribution network, Vista is positioned to make a significant impact in the healthcare landscape.
- Established leader in the Indian pharmaceutical industry
- Focus on innovative and effective healthcare solutions
- Strong commitment to research and development
- Diverse portfolio addressing various health needs
- Robust distribution network for widespread access
Investment Thesis
Vista Pharmaceuticals Ltd stands out due to its strong promoter credibility, positioning it for sustainable growth. The company is leveraging digital services, tapping into a burgeoning market. With attractive valuations compared to peers, Vista presents a compelling investment opportunity for retail investors seeking growth potential.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust financial health supports future expansion and innovation.
- Strategic initiatives in place to capture emerging market opportunities.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong pipeline of new drugs
- Potential for international expansion
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory challenges in drug approvals
- High competition in pharmaceutical sector
- Dependence on few key products
- Market volatility affecting stock price
Peer Perspective
Vista Pharmaceuticals Ltd trades at a discount to peers like Sun Pharma and Dr. Reddy's, primarily due to margin volatility. A stable margin outlook could trigger a rerating, aligning it more closely with its competitors.
Future Outlook
Vista Pharmaceuticals Ltd is poised for growth, driven by innovative product pipelines and expanding market opportunities; however, successful execution and stringent cost control will be critical to achieving our long-term objectives.
AI FAQs for Retail Users
- Q: What does Vista Pharmaceuticals Ltd do?A: Vista Pharmaceuticals Ltd focuses on developing and manufacturing pharmaceutical products for various therapeutic areas.
- Q: Is Vista Pharmaceuticals Ltd listed on Indian stock exchanges?A: Yes, Vista Pharmaceuticals Ltd is listed on major Indian stock exchanges.
- Q: What factors can affect Vista Pharmaceuticals Ltd's stock price?A: Stock price may be influenced by company performance, market trends, regulatory changes, and overall economic conditions.
- Q: How can I invest in Vista Pharmaceuticals Ltd?A: You can invest through a brokerage account by purchasing shares on the stock exchange.
- Q: What are the risks of investing in Vista Pharmaceuticals Ltd?A: Investing in stocks involves risks, including market volatility and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Vista Pharmaceuticals Ltd • Updated: 2025-09-18 01:40:31
-
8BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
9ValuationHighP/E and P/B ratios are higher than industry average.
-
7BalanceHighManageable debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodLimited growth drivers identified; execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Vista Pharmaceuticals Ltd shows potential but faces significant risks and challenges in growth and profitability.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100